Literature DB >> 21268021

An intrinsic B-cell defect supports autoimmunity in New Zealand black chromosome 13 congenic mice.

Christina Loh1, Evelyn Pau, Nan-Hua Chang, Joan E Wither.   

Abstract

Introgression of a New Zealand Black (NZB) chromosome 13 interval onto a C57BL/6 (B6) background (B6.NZBc13) is sufficient to produce many hallmarks of lupus, including high-titre anti-chromatin antibody production, abnormal B- and T-cell activation, and renal disease. In this study we sought to characterize the immune defects leading to these abnormalities. By generating hematopoietic chimeras and BCR transgenic mice, we show that the congenic autoimmune phenotype can be transferred by BM cells and requires the presence of autoreactive B cells. Using the hen egg white lysozyme immunoglobulin transgenic mouse model, we demonstrate that B-cell anergy, deletion, and receptor editing are intact. Nevertheless, congenic B cells exhibit altered peripheral B-cell selection, as demonstrated by enhanced survival and activation of endogenous B cells with autoreactivity to chromatin and Sm/ribonucleoprotein. Given the autoantibody specificities to nuclear antigens, TLR signalling was assessed. B6.NZBc13 B cells were hyper-responsive to poly(I:C), a TLR3 ligand, demonstrating enhanced proliferation and survival as compared to B6 B cells. Our findings indicate the presence of an intrinsic B-cell defect on NZB chromosome 13 that results in hyper-responsiveness to a dsRNA analogue and implicates its potential supporting role in the generation of autoimmunity in B6.NZBc13 mice.
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21268021     DOI: 10.1002/eji.201040983

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  7 in total

1.  The transcription factor Bright plays a role in marginal zone B lymphocyte development and autoantibody production.

Authors:  Athenia L Oldham; Cathrine A Miner; Hong-Cheng Wang; Carol F Webb
Journal:  Mol Immunol       Date:  2011-10-02       Impact factor: 4.407

2.  Activation of autoreactive B cells by endogenous TLR7 and TLR3 RNA ligands.

Authors:  Nathaniel M Green; Krishna-Sulayman Moody; Michelle Debatis; Ann Marshak-Rothstein
Journal:  J Biol Chem       Date:  2012-09-27       Impact factor: 5.157

3.  Suppression of autoimmunity by CD5(+) IL-10-producing B cells in lupus-prone mice.

Authors:  Y Baglaenko; K P Manion; N-H Chang; C Loh; G Lajoie; J E Wither
Journal:  Genes Immun       Date:  2015-05-14       Impact factor: 2.676

4.  Altered toll-like receptor responsiveness underlies a dominant heritable defect in B cell tolerance in autoimmune New Zealand Black mice.

Authors:  Amy G Clark; Elizabeth S Buckley; Mary H Foster
Journal:  Eur J Immunol       Date:  2018-01-19       Impact factor: 5.532

5.  Aberrant CD40-induced NF-κB activation in human lupus B lymphocytes.

Authors:  Wen Zhang; Qun Shi; Xiaotian Xu; Hua Chen; Wei Lin; Fengchun Zhang; Xiaofeng Zeng; Xuan Zhang; Denian Ba; Wei He
Journal:  PLoS One       Date:  2012-08-27       Impact factor: 3.240

6.  Identification of a lupus-susceptibility locus leading to impaired clearance of apoptotic debris on New Zealand Black chromosome 13.

Authors:  E Pau; C Loh; G E S Minty; N-H Chang; J E Wither
Journal:  Genes Immun       Date:  2013-01-17       Impact factor: 2.676

7.  Increase of MZB1 in B cells in systemic lupus erythematosus: proteomic analysis of biopsied lymph nodes.

Authors:  Aya Miyagawa-Hayashino; Hajime Yoshifuji; Koji Kitagori; Shinji Ito; Takuma Oku; Yoshitaka Hirayama; Adeeb Salah; Toshiki Nakajima; Kaori Kiso; Norishige Yamada; Hironori Haga; Tatsuaki Tsuruyama
Journal:  Arthritis Res Ther       Date:  2018-01-30       Impact factor: 5.156

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.